Clinical Trials Browser

Phase 1/2 × Neoplasms, Squamous Cell × Sorafenib × Clear all

NCT00815295 2014-12-08

Study of Sorafenib/Cetuximab in Head and Neck Cancer

Phase 1/2 Completed

31 enrolled 11 charts

Neoplasms, Squamous Cell